Screener
United Therapeutics UTHR Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
FAQ
- What is United Therapeutics's net income?
- United Therapeutics (UTHR) reported net income of $333M in Q2 2026.
- How has United Therapeutics's net income changed year-over-year?
- United Therapeutics's net income increased by 7.6% year-over-year, from $309.5M to $333M.
- What is the long-term trend for United Therapeutics's net income?
- Over 4 years (2021 to 2025), United Therapeutics's net income has grown at a 29.4% compound annual growth rate (CAGR), from $475.8M to $1.33B.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about United Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude